Clinical trial
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
NCT01736553 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
- Lead sponsor
- Ohio State University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- September 30, 2015
- Enrollment
- 53 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
spinal muscular atrophy (sma)